Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Transplant. Jun 18, 2024; 14(2): 91052
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.91052
Figure 1
Figure 1 Outcomes after hematopoietic cell transplantation according to place of residence. A: Overall survival; B: Event-free survival; C: Graft-versus-host relapse-free survival; D: Non-relapse mortality.
Figure 2
Figure 2 Outcomes after hematopoietic cell transplantation according to the site of diagnosis and treatment. A: Overall survival; B: Event-free survival; C: Graft-versus-host relapse-free survival; D: Non-relapse mortality.
Figure 3
Figure 3 Outcomes according to payment coverage: out-of-pocket, private insurance, or universal coverage. A: Overall survival; B: Event-free survival; C: Graft-versus-host relapse-free survival; D: Non-relapse mortality. OOP: Out-of-pocket.

  • Citation: Gómez-De León A, López-Mora YA, García-Zárate V, Varela-Constantino A, Villegas-De Leon SU, González-Leal XJ, del Toro-Mijares R, Rodríguez-Zúñiga AC, Barrios-Ruiz JF, Mingura-Ledezma V, Colunga-Pedraza PR, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Tarín-Arzaga L, González-López EE, Gómez-Almaguer D. Impact of payment source, referral site, and place of residence on outcomes after allogeneic transplantation in Mexico. World J Transplant 2024; 14(2): 91052
  • URL: https://www.wjgnet.com/2220-3230/full/v14/i2/91052.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v14.i2.91052